The Business Model of Xaira Therapeutics, Inc.
As of November 4, 2026
Xaira Therapeutics, Inc. is a privately held biotechnology company headquartered in South San Francisco, California. The company was founded in 2023 and launched publicly in April 2024.
Xaira applies artificial intelligence across drug discovery and development, combining machine-learning research, purpose-built biological data generation, and therapeutic product development. Its official site describes its aim as developing predictive and agentic AI models to support a pipeline of next-generation medicines; the company also maintains offices in Seattle and London.
Hard Facts
Business Model Canvas
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeBusiness Model Patterns
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free
SWOT Analysis
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeWhat makes Xaira Therapeutics, Inc. special?
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeMarketing Insights
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free